Catalent Pharma Solutions


Catalent Pharma Solutions is the leading global provider of advanced delivery technologies and development solutions for drugs, biologics, consumer health products and global clinical supply services. With over 80 years serving the industry, Catalent has proven expertise in bringing more customer products to market faster, enhancing product performance and ensuring reliable clinical and commercial product supply. Catalent employs approximately 8,000 people, including over 1,000 scientists, at nearly 30 facilities across 5 continents and in fiscal 2014 generated more than $1.8 billion in annual revenue. Catalent is headquartered in Somerset, N.J. For more information, visit

More products. Better treatments. Reliably supplied.™

Related resources

show more

First-in-Human Development Strategies

First-in-Human Development Strategies

Catalent Pharma Solutions | 01-May-2017 | Insight Guide

Crucial and cost-effective factors to consider when transforming a pre-clinical development compound into a first-in-human, early-phase drug candidate....

Patient-Centric Drug-Development Process

Patient-Centric Drug-Development Process

Catalent Pharma Solutions | 28-Nov-2016 | Insight Guide

For large and small pharmaceutical companies alike; developing a new drug is fraught with risk. Patient-centric drug development and optimization is both...